Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: A randomized trial

Thrombosis Research

Volumn 134, Issue 4, 2014, Pages 814-818

  Schulman, S ^a,b   Healey, J S ^a   Douketis, J D ^a   Delaney, J ^a   Morillo, C A ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Anticoagulation; Atrial fibrillation; Defibrillator; Pacemaker; Surgery

Indexed keywords

CLOPIDOGREL; ENOXAPARIN; VITAMIN K GROUP; WARFARIN; ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CARDIOVASCULAR PROCEDURE; CONTROLLED STUDY; DEFIBRILLATOR; DEFIBRILLATOR IMPLANTATION; DRUG DOSE REDUCTION; FEMALE; HEMATOMA; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PACEMAKER; PACEMAKER IMPLANTATION; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM; ARTIFICIAL HEART PACEMAKER; CHEMICALLY INDUCED; CLINICAL TRIAL; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PREOPERATIVE CARE; PREOPERATIVE PERIOD;

ANTICOAGULANTS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEMATOMA; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; PACEMAKER, ARTIFICIAL; PREOPERATIVE CARE; PREOPERATIVE PERIOD; THROMBOEMBOLISM; VITAMIN K; WARFARIN;

EID: 84908210842     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.07.028     Document Type: Article

References (24)

1. McComb JM, Gribbin GM. Chronic atrial fibrillation in patients with paroxysmal atrial fibrillation, atrioventricular node ablation and pacemakers: determinants and treatment. Europace 1999;1:30-4.
2. Wiegand UK, LeJeune D, Boguschewski F, Bonnemeier H, Eberhardt F, Schunkert H, et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest 2004;126:1177-86.
3. Kiviniemi MS, Pirnes MA, Eranen HJ, Kettunen RV, Hartikainen JE. Complications related to permanent pacemaker therapy. Pacing Clin Electrophysiol 1999;22:711-20.
4. Aggarwal RK, Connelly DT, Ray SG, Ball J, Charles RG. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems. Br Heart J 1995;73:571-5.
5. Jamula E, Douketis JD, Schulman S. Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide. J Thromb Haemost 2008;6:1615-21.
6. Phibbs B, Marriott HJ. Complications of permanent transvenous pacing. N Engl J Med 1985;312:1428-32.
7. Robinson M, Healey JS, Eikelboom J, Schulman S, Morillo CA, Nair GM, et al. Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators. Pacing Clin Electrophysiol 2009;32:378-82.
8. Larson BJ, Zumberg MS, Kitchens CS. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk. Chest 2005;127:922-7.
9. Marietta M, Bertesi M, Simoni L, Pozzi S, Castelli I, Cappi C, et al. A simple and safe nomogram for the management of oral anticoagulation prior to minor surgery. Clin Lab Haematol 2003;25:127-30.
10. Sacco R, Sacco M, Carpenedo M, Moia M. Oral surgery in patients on oral anticoagulant therapy: a randomized comparison of different INR targets. J Thromb Haemost 2006;4:688-9.
11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
12. Schulman S, Earl B, Robinson M. Perioperative management of anticoagulation with tapered dose warfarin. Haematologica 2008;93(s1):147-8.
13. Zisman E, Erport A, Kohanovsky E, Ballagulah M, Cassel A, Quitt M, et al. Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients. Eur J Anaesthesiol 2010;27:617-23.
14. Li C, Hirsh J, Xie C, Johnston MA, Eikelboom JW. Reversal of the anti-platelet effects of aspirin and clopidogrel. J Thromb Haemost 2012;10:521-8.
15. Schulman S, Angeras U, Bergqvist D, Eriksson B, Lassen MR, Fisher W. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost 2010;8:202-4.
16. Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, et al. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med 2013;368:2084-93.
17. al-Khadra AS. Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients. Pacing Clin Electrophysiol 2003;26:511-4.
18. Denman RA, Walters DL, Twidale N, Masterson ML. The implantation of permanent pacemakers and automatic implantable cardiac defibrillators in patients on warfarin. CSANZ 47 Annual Scientific Meeting; 1999 [www.csanz.edu.au/abstracts/47abstracts/041.doc.htm].
19. Giudici MC, Barold SS, Paul DL, Bontu P. Pacemaker and implantable cardioverter de fibrillator implantation without reversal of warfarin therapy. Pacing Clin Electrophysiol 2004;27:358-60.
20. Goldstein DJ, Losquadro W, Spotnitz HM. Outpatient pacemaker procedures in orally anticoagulated patients. Pacing Clin Electrophysiol 1998;21:1730-4.
21. Michaud GF, Pelosi Jr F, Noble MD, Knight BP, Morady F, Strickberger SA. A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation. J Am Coll Cardiol 2000;35:1915-8.
22. Milic DJ, Perisic ZD, Zivic SS, Stanojkovic ZA, Stojkovic AM, Karanovic ND, et al. Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment. Europace 2005;7:374-9.
23. Tischenko A, Gula LJ, Yee R, Klein GJ, Skanes AC, Krahn AD. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin. Am Heart J 2009;158:252-6.
24. Tolosana JM, Berne P, Mont L, Heras M, Berruezo A, Monteagudo J, et al. Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial. Eur Heart J 2009;30:1880-4.